Skip to main content
NVDA0.00%AAPL-0.04%GOOGL-3.15%MSFT0.00%AMZN+0.10%TSM-4.52%SPCX-9.14%META-0.52%AVGO-4.31%TSLA-0.38%LLY+2.83%BRK-B+1.50%MU-1.05%WMT+2.82%SKHY-8.07%JPM+0.40%AMD-8.10%V+1.59%XOM+0.08%JNJ+3.81%ASMLa-4.74%MA+1.70%ABBV+0.03%INTC-8.04%COST+1.99%CVX-0.04%0700.HK-2.89%1398.HK-1.34%CSCO-2.21%KO+2.87%PG+5.58%UNH+1.91%ORCL-2.80%BAC+0.59%1816.HK-0.22%3988.HK-1.80%HD+4.33%CAT-4.89%0005.HK-1.23%PM+2.17%HSBA.L-2.45%0857.HK-0.82%GE-0.79%AP2d-6.79%1288.HK-0.30%0939.HK-0.61%AMAT-8.16%NVS+1.52%MS-1.63%DELL-6.78%PLNJPY-1.46%EURAUD-1.28%EURCAD-1.15%AUDUSD+1.06%EURJPY-0.96%USDCAD-0.91%USDTHB+0.86%SGDJPY-0.84%GBPZAR+0.78%USDJPY-0.77%USDZAR+0.77%EURNZD-0.75%EURGBP-0.75%CHFSEK+0.73%AUDCHF+0.64%USDPLN+0.64%EURCHF-0.62%EURZAR+0.58%NZDUSD+0.54%NOKJPY-0.54%GBPAUD-0.53%GBPUSD+0.53%AUDNZD+0.52%CADCHF+0.52%EURNOK-0.48%CHFSGD+0.46%EURPLN+0.45%AUDNOK-0.43%GBPCAD-0.42%GBPTRY+0.41%USDCHF-0.41%NZDCAD-0.39%CHFJPY-0.38%AUDJPY+0.33%NZDSGD-0.32%GBPHKD+0.32%EURHKD-0.31%USDNOK-0.30%GBPMXN-0.28%USDSEK+0.27%NZDJPY-0.24%GBPJPY-0.24%EURUSD-0.22%USDTRY+0.20%USDCNH-0.20%EURCNH-0.19%USDMXN+0.18%CADJPY+0.18%EURSGD-0.17%USDDKK+0.17%USDILS+0.16%NZDMXN-0.15%CHFNOK+0.15%USDHKD-0.15%AUDCAD+0.14%AUDSGD-0.13%NZDCHF+0.12%GBPCHF+0.11%EURSEK+0.10%EURCZK+0.05%AUDDKK+0.04%USDCOP-0.04%GBPNZD-0.03%GBPSGD+0.02%EURDKK-0.01%USDSGD0.00%GAGUSD-5.89%XAGUSD-5.89%XPTUSD-4.00%GAUUSD-2.84%XAUUSD-2.84%HG1-2.70%UKOIL+2.43%USOIL+1.35%SUGAR0.00%XNGUSD0.00%COFFEE0.00%COCOA0.00%BTCUSD-3.35%ETHUSD+16.36%USDTUSD-0.02%XRPUSD+9.91%SOLUSD+10.75%TRXUSDT-0.75%ZECUSDT-7.95%DOGEUSD+14.39%XMRUSDT-1.77%LINKUSD+14.52%XLMUSD-4.59%BCHUSDT-4.51%LTCUSD+8.69%UNIUSD-6.06%SUIUSD-5.62%HBARUSDT-6.18%TONUSD+26.39%TAOUSDT-5.75%AAVEUSD-5.52%DOTUSDT-3.05%ICPUSDT-6.22%WLDUSDT-7.21%ONDOUSDT-7.19%ARBUSDT-4.79%JUPUSDT-5.17%ATOMUSDT-3.26%INJUSDT-8.12%STXUSDT-11.12%TIAUSDT-6.23%FETUSDT-6.08%PYTHUSDT-7.51%SEIUSDT-9.27%IMXUSDT-7.91%GRTUSDT-6.54%OPUSDT-8.75%WIFUSDT-6.99%IOTAUSDT-5.48%AXSUSDT-5.93%POLUSDT-4.92%FARTCOINUSDT-5.87%EOSUSDT-2.04%DYDXUSDT-6.41%GALAUSDT-5.09%ORDIUSDT-3.33%RONINUSDT-5.30%NOTUSDT-4.94%NVDA0.00%AAPL-0.04%GOOGL-3.15%MSFT0.00%AMZN+0.10%TSM-4.52%SPCX-9.14%META-0.52%AVGO-4.31%TSLA-0.38%LLY+2.83%BRK-B+1.50%MU-1.05%WMT+2.82%SKHY-8.07%JPM+0.40%AMD-8.10%V+1.59%XOM+0.08%JNJ+3.81%ASMLa-4.74%MA+1.70%ABBV+0.03%INTC-8.04%COST+1.99%CVX-0.04%0700.HK-2.89%1398.HK-1.34%CSCO-2.21%KO+2.87%PG+5.58%UNH+1.91%ORCL-2.80%BAC+0.59%1816.HK-0.22%3988.HK-1.80%HD+4.33%CAT-4.89%0005.HK-1.23%PM+2.17%HSBA.L-2.45%0857.HK-0.82%GE-0.79%AP2d-6.79%1288.HK-0.30%0939.HK-0.61%AMAT-8.16%NVS+1.52%MS-1.63%DELL-6.78%PLNJPY-1.46%EURAUD-1.28%EURCAD-1.15%AUDUSD+1.06%EURJPY-0.96%USDCAD-0.91%USDTHB+0.86%SGDJPY-0.84%GBPZAR+0.78%USDJPY-0.77%USDZAR+0.77%EURNZD-0.75%EURGBP-0.75%CHFSEK+0.73%AUDCHF+0.64%USDPLN+0.64%EURCHF-0.62%EURZAR+0.58%NZDUSD+0.54%NOKJPY-0.54%GBPAUD-0.53%GBPUSD+0.53%AUDNZD+0.52%CADCHF+0.52%EURNOK-0.48%CHFSGD+0.46%EURPLN+0.45%AUDNOK-0.43%GBPCAD-0.42%GBPTRY+0.41%USDCHF-0.41%NZDCAD-0.39%CHFJPY-0.38%AUDJPY+0.33%NZDSGD-0.32%GBPHKD+0.32%EURHKD-0.31%USDNOK-0.30%GBPMXN-0.28%USDSEK+0.27%NZDJPY-0.24%GBPJPY-0.24%EURUSD-0.22%USDTRY+0.20%USDCNH-0.20%EURCNH-0.19%USDMXN+0.18%CADJPY+0.18%EURSGD-0.17%USDDKK+0.17%USDILS+0.16%NZDMXN-0.15%CHFNOK+0.15%USDHKD-0.15%AUDCAD+0.14%AUDSGD-0.13%NZDCHF+0.12%GBPCHF+0.11%EURSEK+0.10%EURCZK+0.05%AUDDKK+0.04%USDCOP-0.04%GBPNZD-0.03%GBPSGD+0.02%EURDKK-0.01%USDSGD0.00%GAGUSD-5.89%XAGUSD-5.89%XPTUSD-4.00%GAUUSD-2.84%XAUUSD-2.84%HG1-2.70%UKOIL+2.43%USOIL+1.35%SUGAR0.00%XNGUSD0.00%COFFEE0.00%COCOA0.00%BTCUSD-3.35%ETHUSD+16.36%USDTUSD-0.02%XRPUSD+9.91%SOLUSD+10.75%TRXUSDT-0.75%ZECUSDT-7.95%DOGEUSD+14.39%XMRUSDT-1.77%LINKUSD+14.52%XLMUSD-4.59%BCHUSDT-4.51%LTCUSD+8.69%UNIUSD-6.06%SUIUSD-5.62%HBARUSDT-6.18%TONUSD+26.39%TAOUSDT-5.75%AAVEUSD-5.52%DOTUSDT-3.05%ICPUSDT-6.22%WLDUSDT-7.21%ONDOUSDT-7.19%ARBUSDT-4.79%JUPUSDT-5.17%ATOMUSDT-3.26%INJUSDT-8.12%STXUSDT-11.12%TIAUSDT-6.23%FETUSDT-6.08%PYTHUSDT-7.51%SEIUSDT-9.27%IMXUSDT-7.91%GRTUSDT-6.54%OPUSDT-8.75%WIFUSDT-6.99%IOTAUSDT-5.48%AXSUSDT-5.93%POLUSDT-4.92%FARTCOINUSDT-5.87%EOSUSDT-2.04%DYDXUSDT-6.41%GALAUSDT-5.09%ORDIUSDT-3.33%RONINUSDT-5.30%NOTUSDT-4.94%
BS

Boston Scientific Corporation (BSX)

NYSE • Healthcare

$46.01
+$1.5 (+3.4%)
Market closed

Last close at October 22, 2026 at 20:00 UTC

Open$44.72
Day Range$44.62 - $46.05
Avg. Volume (3M)15.8M
Market Cap$66.6B
P/E Ratio18.6
52 Week Range
$41.39$105.65
Next EarningsIn 6 daysOct 28, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$5.4B100%
Gross Profitminus cost of goods$3.8B71%
Operating Incomeminus R&D and overhead$1.1B22%
Net Incomeminus taxes and the rest$907M17%

In plain terms: out of every $100 in revenue, Boston Scientific Corporation keeps $17 as net profit.

Fundamentals & Financials

Revenue (TTM)
$20.9B
Net Income (TTM)
$3.6B
EPS (TTM)
$2.48
ROA (TTM)
8.11%
Current Ratio
1.24
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+2.4%Q1 2026$0.8
+1.5%Q2 2026$0.8
+3.0%Q3 2026$0.86
Next

Oct 28

in 6 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +3.0%

Boston Scientific’s adjusted EPS topped consensus and revenue edged past estimates in the second fiscal quarter of 2026, reported July 29, based on preliminary results. Revenue rose 7.5% to about $5.4 billion, above the $5.37 billion estimate, while adjusted EPS of $0.86 beat the $0.83 consensus by 3.2% and came in up from $0.75 a year ago. Net income increased 14.8% to about $910 million from $793 million a year earlier, with gross margin near 70.7% and operating margin about 22.2% as operating income reached roughly $1.2 billion. Operating cash flow was about $348 million. For the next period, consensus for the next period calls for EPS of $0.84 on revenue of $5.34 billion.

Next report — what to expect

Boston Scientific Corporation (BSX) reports on October 28, 2026. Wall Street is looking for EPS of $0.77 on revenue of $5.16 billion. For trailing context, revenue grew +7.5% year over year last quarter. BSX has beaten EPS in 8 of its 8 most recent quarters.

View full earnings history

About Boston Scientific Corporation

Boston Scientific Corporation designs, manufactures, and commercializes medical devices for cardiovascular, rhythm-management, neurostimulation, and procedural care markets. Listed on the NYSE as BSX, the company operates in healthcare as a medical-device maker and generated $20.1 billion in revenue in FY2025.

Name
Boston Scientific Corporation
CEO
Michael F. Mahoney
Website
www.bostonscientific.com
Industry
Healthcare
Year Founded
1979
Employees
59,000

Today's Snapshot

AI-generated

BSX closed 3.4% higher at 46.02, in line with a firmer sector. Boston Scientific faces a patent lawsuit. Earnings are due from BSX on 28 October.

Trading Volume

Below 10d avg (14.2M)

12.5M

vs S&P 500 Today

Strong Outperformance

+4.65%

Updated: October 22, 2026 at 20:09 UTC

Technical Indicators

4 Buy1 Neutral3 Sell
BSX presents a neutral picture as short-term averages and momentum indicators are constructive while longer-term averages remain well above the current price, producing a balance of forces. Momentum measures show strength—CCI and recent moving averages are supportive—yet oscillators and ADX are moderate, and Bollinger band placement suggests the price is extended versus recent volatility. Volume metrics are mixed, with a negative cumulative OBV contrasting with bullish short-term price action, and ATR indicates only modest volatility. Technical takeaway: short-term strength is offset by longer-term average resistance and mixed volume, producing a neutral technical posture.
All signals
  • EMA (5 indicators)$44.21 - $61.10
    Buy
  • RSI (14)59.27
    Neutral
  • Stochastic %K (14, 3, 3)85.41
    Sell
  • MACD Level (12, 26)0.05
    Buy

Peers & Related Assets

MDTMedtronic Plc
$96.59+3.8%
EWEdwards Lifesciences Corporation
$90.09+1.9%
PENPenumbra, Inc.
$324.96+0.4%
TFXTeleflex Incorporated
$136.58+4.7%
MMSIMerit Medical Systems, Inc.
$93.94+2.8%
LIVNLivaNova PLC
$81.27+3.6%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.